|
| 37466221 | Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial. | J Infect Dis | 2024 |
| 36131321 | The Coronavirus Disease 2019 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to Action. | Clin Infect Dis | 2023 |
| 37561027 | Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. | J Infect Dis | 2023 |
| 37057755 | Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture-derived H5N1 (aH5n1c) influenza vaccine in adults and older adults. | Hum Vaccin Immunother | 2023 |
| 36947462 | Erythema and Induration after Mpox (JYNNEOS) Vaccination Revisited. | N Engl J Med | 2023 |
| 37075127 | Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial. | Sci Transl Med | 2023 |
| 37205592 | Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial. | Res Sq | 2023 |
| 37036397 | Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial. | Clin Infect Dis | 2023 |
| 37034641 | Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial. | medRxiv | 2023 |
| 36610741 | Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adults. | Clin Infect Dis | 2023 |
| 36610728 | Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses. | Clin Infect Dis | 2023 |
| 36941155 | Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults - A randomized clinical trial. | Vaccine | 2023 |
| 36702771 | A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults. | J Infect Dis | 2023 |
| 35202354 | Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations - United States, 2021. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35511716 | Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35674154 | Universal hepatitis B vaccination in adults aged 19-59â¿¿years: Updated recommendations of the advisory committee on immunization practices-United States, 2022. | Am J Transplant | 2022 |
| 35358162 | Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35898343 | SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses. | medRxiv | 2022 |
| 35959208 | Clinical Features and Treatment Outcomes of Pulmonary <i>Mycobacterium avium-intracellulare</i> Complex With and Without Coinfections. | Open Forum Infect Dis | 2022 |
| 35012764 | Effects of race on the outcome of COVID-19 in hospitalized patients. | J Natl Med Assoc | 2022 |
| 35125224 | MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly. | Vaccine | 2022 |
| 35125219 | A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system. | Vaccine | 2022 |
| 32198521 | Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease. | Clin Infect Dis | 2021 |
| 33485646 | Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65Â years and older. | Vaccine | 2021 |
| 33505681 | Vaccine-related major cutaneous reaction size correlates with cellular-mediated immune responses after tularaemia immunisation. | Clin Transl Immunology | 2021 |
| 33378609 | Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. | N Engl J Med | 2021 |
| 33417593 | Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. | MMWR Recomm Rep | 2021 |
| 32308219 | COVID-19 Teaches Hard Lessons. | Mo Med | 2020 |
| 31809725 | Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B-Cell-Based Vaccine Development. | Gastroenterology | 2020 |
| 32571718 | Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants. | Vaccine | 2020 |
| 32748963 | Rapid establishment of a COVID-19 convalescent plasma program in a regional health care delivery network. | Transfusion | 2020 |
| 30587533 | Mupirocin for <i>Staphylococcus aureus</i> Decolonization of Infants in Neonatal Intensive Care Units. | Pediatrics | 2019 |
| 30968056 | Safety and Immunogenicity of MF59-Adjuvanted Cell Culture-Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly. | Open Forum Infect Dis | 2019 |
| 29344356 | Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia. | Ther Adv Infect Dis | 2018 |
| 29961606 | Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women. | Vaccine | 2018 |
| 30416018 | Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women. | Vaccine | 2018 |
| 29428177 | Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series. | Vaccine | 2018 |
| 29306506 | Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals. | Vaccine | 2018 |
| 28750854 | Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial. | Vaccine | 2017 |
| 28256358 | Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial. | Vaccine | 2017 |
| 28249841 | B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. | Clin Vaccine Immunol | 2017 |
| 29037578 | A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066). | Vaccine | 2017 |
| 27443611 | Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination. | J Infect Dis | 2016 |
| 26657997 | Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine. | Vaccine | 2016 |
| 25444793 | Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine. | Vaccine | 2015 |
| 26251214 | Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activity. | Hepatology | 2015 |
| 26319063 | Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine. | Vaccine | 2015 |
| 26197184 | Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial. | JAMA | 2015 |
| 26143613 | Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects. | Vaccine | 2015 |
| 25712967 | Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine. | J Infect Dis | 2015 |